Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in AMNEAL PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 243,133 shares of AMRX (AMNEAL PHARMACEUTICALS INC), worth $3.1M as of 2025-Q4. The position was increased (++4.0% shares). AMRX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$3.1M
Current Shares
243,133
Total Value Change
+$1.4M
Total Shares Change
-21,591
Other major holders of AMRX: BNP PARIBAS FINANCIAL MARKETS
Increased |
| 243,133 |
+4.0% |
| $3.1M |
| 0.0% |
| $12.88 |
27 |
| 2025-Q3 | Decreased | 233,895 | -50.3% | $2.3M | 0.0% | $9.87 | 0 |
| 2025-Q2 | Increased | 470,432 | +40.5% | $3.8M | 0.0% | $8.13 | 35 |
| 2025-Q1 | Increased | 334,956 | +5.2% | $2.8M | 0.0% | $8.28 | 28 |
| 2024-Q4 | Increased | 318,420 | +45.7% | $2.5M | 0.0% | $7.83 | 36 |
| 2024-Q3 | Decreased | 218,554 | -17.4% | $1.8M | 0.0% | $8.19 | 0 |
| 2024-Q2 | Increased | 264,724 | +626.7% | $1.7M | 0.0% | $6.35 | 41 |